The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Travel, Accommodations, Expenses - Lilly; MSD; Novartis; Pfizer; Roche
Pooled mutation analysis for the NP28673 and NP28761 studies of alectinib in ALK+ non-small-cell lung cancer (NSCLC).
 
Oscar Puig
Employment - Proacta
Stock and Other Ownership Interests - Proacta
 
James Chih-Hsin Yang
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; MSD; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; AstraZeneca (Inst); Bayer; Boehringer Ingelheim; Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Celgene; Clovis Oncology; Lilly; Merck Serono; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Roche/Genentech
 
Sai-Hong Ignatius Ou
Honoraria - Pfizer; Roche Pharma AG
Consulting or Advisory Role - Pfizer; Roche/Genentech
Speakers' Bureau - Boehringer Ingelheim; Genentech
Research Funding - ARIAD (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Chugai Pharma (Inst); Clovis Oncology (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Peregrine Pharmaceuticals (Inst); Pfizer (Inst); Roche Pharma AG (Inst)
 
Alberto Chiappori
Consulting or Advisory Role - Celgene; Genentech; Novartis; Pfizer
Speakers' Bureau - Boehringer Ingelheim; Celgene; Genentech; Merck; Novartis; Pfizer
 
Bo H Chao
No Relationships to Disclose
 
Chandra Prakash Belani
No Relationships to Disclose
 
Alexander I. Spira
Honoraria - Novartis; Roche
Research Funding - Astellas Pharma; AstraZeneca; Boehringer Ingelheim; Clovis Oncology; MedImmune; Roche
Expert Testimony - Novartis
Travel, Accommodations, Expenses - Roche
 
Alessandra Bearz
No Relationships to Disclose
 
Michael Duruisseaux
No Relationships to Disclose
 
John Allard
Employment - Roche
Stock and Other Ownership Interests - Roche
Research Funding - Roche
 
Fabian Birzele
Employment - Roche Pharma AG
Research Funding - Roche Pharma AG
Patents, Royalties, Other Intellectual Property - Roche Pharma AG
 
Frederic Boisserie
Employment - Roche
Stock and Other Ownership Interests - Roche/Genentech
 
Ulrika Lonngren
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Walter Bordogna
Employment - Proacta
Stock and Other Ownership Interests - Proacta
 
Daniel M. Klass
Employment - Roche Molecular Diagnostics
Consulting or Advisory Role - CAPP Medical
Patents, Royalties, Other Intellectual Property - Stanford University
 
Aaron M. Newman
Consulting or Advisory Role - Roche
Patents, Royalties, Other Intellectual Property - Stanford University
 
Ali Hassan Zeaiter
Employment - Proacta
Leadership - Proacta
Stock and Other Ownership Interests - Proacta
 
Alice Tsang Shaw
Honoraria - Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - ARIAD; Blueprint Medicines; Daiichi Sankyo; EMD Serono; Genentech; Ignyta; Novartis; Pfizer; Roche; Taiho Pharmaceutical
Research Funding - Novartis; Pfizer; Roche/Genentech